
Under intense criticism, Gilead forsakes monopoly status for its experimental Covid-19 drug
In an unexpected move, Gilead Sciences (GILD) has asked the Food and Drug Administration to…

In an unexpected move, Gilead Sciences (GILD) has asked the Food and Drug Administration to…